APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Docetaxel

Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.

Selected research

Market Analysis & Forecast

Global Docetaxel Market Analysis and Forecast 2026-2032

Report ID 173985430222 December 2025195 pages

Choose your research edition.

Industry ResearchDocetaxel Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Docetaxel Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Docetaxel Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Docetaxel Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Docetaxel Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.

China Docetaxel key players include Hengrui Medicine, Sanofi, Qilu Pharma, Shenzhen Main Luck Pharma, etc. Top four companies hold a share over 80%. In terms of product, 20 mg/ml is the largest segment, with a share nearly 85%.

This report presents an overview of global market for Docetaxel, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Docetaxel, also provides the sales of main regions and countries. Of the upcoming market potential for Docetaxel, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Docetaxel sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Docetaxel market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Docetaxel sales, projected growth trends, production technology, application and end-user industry.

Docetaxel Segment by Company

Hengrui Medicine

Sanofi

Qilu Pharma

Shenzhen Main Luck Pharma

Jiangsu Aosaikang Pharma

Docetaxel Segment by Type

20 mg/ml

40 mg/ml

60 mg/ml

Docetaxel Segment by Application

Breast Cancer

Prostate Cancer

Non-small Cell Lung Cancer

Others

Docetaxel Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Docetaxel market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Docetaxel and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Docetaxel.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Docetaxel in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Docetaxel manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Docetaxel sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Docetaxel Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 20 mg/ml Major Manufacturers Table 3. 40 mg/ml Major Manufacturers Table 4. 60 mg/ml Major Manufacturers Table 5. Global Docetaxel Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Breast Cancer Major Manufacturers Table 7. Prostate Cancer Major Manufacturers Table 8. Non-small Cell Lung Cancer Major Manufacturers Table 9. Others Major Manufacturers Table 10. Docetaxel Industry Trends Table 11. Docetaxel Industry Drivers Table 12. Docetaxel Industry Opportunities and Challenges Table 13. Docetaxel Industry Restraints Table 14. Global Docetaxel Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Docetaxel Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Docetaxel Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Docetaxel Revenue Market Share by Region (2021-2026) Table 18. Global Docetaxel Revenue Market Share by Region (2027-2032) Table 19. Global Docetaxel Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Docetaxel Sales by Region (2021-2026) & (K Units) Table 21. Global Docetaxel Sales by Region (2027-2032) & (K Units) Table 22. Global Docetaxel Sales Market Share by Region (2021-2026) Table 23. Global Docetaxel Sales Market Share by Region (2027-2032) Table 24. Global Docetaxel Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Docetaxel Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Docetaxel Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Docetaxel Sales Market Share by Manufacturers (2021-2026) Table 28. Global Docetaxel Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 29. Global Docetaxel Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Docetaxel Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Docetaxel Manufacturers, Product Type & Application Table 32. Global Docetaxel Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Docetaxel by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Docetaxel Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Docetaxel Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Docetaxel Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Docetaxel Revenue Market Share by Type (2021-2026) Table 39. Global Docetaxel Revenue Market Share by Type (2027-2032) Table 40. Global Docetaxel Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Docetaxel Sales by Type (2021-2026) & (K Units) Table 42. Global Docetaxel Sales by Type (2027-2032) & (K Units) Table 43. Global Docetaxel Sales Market Share by Type (2021-2026) Table 44. Global Docetaxel Sales Market Share by Type (2027-2032) Table 45. Global Docetaxel Price by Type (2021-2026) & (USD/Unit) Table 46. Global Docetaxel Price by Type (2027-2032) & (USD/Unit) Table 47. Global Docetaxel Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Docetaxel Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Docetaxel Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Docetaxel Revenue Market Share by Application (2021-2026) Table 51. Global Docetaxel Revenue Market Share by Application (2027-2032) Table 52. Global Docetaxel Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Docetaxel Sales by Application (2021-2026) & (K Units) Table 54. Global Docetaxel Sales by Application (2027-2032) & (K Units) Table 55. Global Docetaxel Sales Market Share by Application (2021-2026) Table 56. Global Docetaxel Sales Market Share by Application (2027-2032) Table 57. Global Docetaxel Price by Application (2021-2026) & (USD/Unit) Table 58. Global Docetaxel Price by Application (2027-2032) & (USD/Unit) Table 59. Hengrui Medicine Company Information Table 60. Hengrui Medicine Business Overview Table 61. Hengrui Medicine Docetaxel Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 62. Hengrui Medicine Docetaxel Product Portfolio Table 63. Hengrui Medicine Recent Development Table 64. Sanofi Company Information Table 65. Sanofi Business Overview Table 66. Sanofi Docetaxel Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 67. Sanofi Docetaxel Product Portfolio Table 68. Sanofi Recent Development Table 69. Qilu Pharma Company Information Table 70. Qilu Pharma Business Overview Table 71. Qilu Pharma Docetaxel Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 72. Qilu Pharma Docetaxel Product Portfolio Table 73. Qilu Pharma Recent Development Table 74. Shenzhen Main Luck Pharma Company Information Table 75. Shenzhen Main Luck Pharma Business Overview Table 76. Shenzhen Main Luck Pharma Docetaxel Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 77. Shenzhen Main Luck Pharma Docetaxel Product Portfolio Table 78. Shenzhen Main Luck Pharma Recent Development Table 79. Jiangsu Aosaikang Pharma Company Information Table 80. Jiangsu Aosaikang Pharma Business Overview Table 81. Jiangsu Aosaikang Pharma Docetaxel Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 82. Jiangsu Aosaikang Pharma Docetaxel Product Portfolio Table 83. Jiangsu Aosaikang Pharma Recent Development Table 84. North America Docetaxel Revenue by Type (2021-2026) & (US$ Million) Table 85. North America Docetaxel Revenue by Type (2027-2032) & (US$ Million) Table 86. North America Docetaxel Sales by Type (2021-2026) & (K Units) Table 87. North America Docetaxel Sales by Type (2027-2032) & (K Units) Table 88. North America Docetaxel Sales Price by Type (2021-2026) & (USD/Unit) Table 89. North America Docetaxel Sales Price by Type (2027-2032) & (USD/Unit) Table 90. North America Docetaxel Revenue by Application (2021-2026) & (US$ Million) Table 91. North America Docetaxel Revenue by Application (2027-2032) & (US$ Million) Table 92. North America Docetaxel Sales by Application (2021-2026) & (K Units) Table 93. North America Docetaxel Sales by Application (2027-2032) & (K Units) Table 94. North America Docetaxel Sales Price by Application (2021-2026) & (USD/Unit) Table 95. North America Docetaxel Sales Price by Application (2027-2032) & (USD/Unit) Table 96. North America Docetaxel Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. North America Docetaxel Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 98. North America Docetaxel Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 99. North America Docetaxel Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 100. North America Docetaxel Sales by Country (2021-2026) & (K Units) Table 101. North America Docetaxel Sales by Country (2027-2032) & (K Units) Table 102. North America Docetaxel Sales Price by Country (2021-2026) & (USD/Unit) Table 103. North America Docetaxel Sales Price by Country (2027-2032) & (USD/Unit) Table 104. United States Docetaxel Revenue (2021-2032) & (US$ Million) Table 105. Canada Docetaxel Revenue (2021-2032) & (US$ Million) Table 106. Mexico Docetaxel Revenue (2021-2032) & (US$ Million) Table 107. Europe Docetaxel Revenue by Type (2021-2026) & (US$ Million) Table 108. Europe Docetaxel Revenue by Type (2027-2032) & (US$ Million) Table 109. Europe Docetaxel Sales by Type (2021-2026) & (K Units) Table 110. Europe Docetaxel Sales by Type (2027-2032) & (K Units) Table 111. Europe Docetaxel Sales Price by Type (2021-2026) & (USD/Unit) Table 112. Europe Docetaxel Sales Price by Type (2027-2032) & (USD/Unit) Table 113. Europe Docetaxel Revenue by Application (2021-2026) & (US$ Million) Table 114. Europe Docetaxel Revenue by Application (2027-2032) & (US$ Million) Table 115. Europe Docetaxel Sales by Application (2021-2026) & (K Units) Table 116. Europe Docetaxel Sales by Application (2027-2032) & (K Units) Table 117. Europe Docetaxel Sales Price by Application (2021-2026) & (USD/Unit) Table 118. Europe Docetaxel Sales Price by Application (2027-2032) & (USD/Unit) Table 119. Europe Docetaxel Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Europe Docetaxel Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 121. Europe Docetaxel Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 122. Europe Docetaxel Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 123. Europe Docetaxel Sales by Country (2021-2026) & (K Units) Table 124. Europe Docetaxel Sales by Country (2027-2032) & (K Units) Table 125. Europe Docetaxel Sales Price by Country (2021-2026) & (USD/Unit) Table 126. Europe Docetaxel Sales Price by Country (2027-2032) & (USD/Unit) Table 127. Germany Docetaxel Revenue (2021-2032) & (US$ Million) Table 128. France Docetaxel Revenue (2021-2032) & (US$ Million) Table 129. U.K. Docetaxel Revenue (2021-2032) & (US$ Million) Table 130. Italy Docetaxel Revenue (2021-2032) & (US$ Million) Table 131. Russia Docetaxel Revenue (2021-2032) & (US$ Million) Table 132. Spain Docetaxel Revenue (2021-2032) & (US$ Million) Table 133. Netherlands Docetaxel Revenue (2021-2032) & (US$ Million) Table 134. Switzerland Docetaxel Revenue (2021-2032) & (US$ Million) Table 135. Sweden Docetaxel Revenue (2021-2032) & (US$ Million) Table 136. Poland Docetaxel Revenue (2021-2032) & (US$ Million) Table 137. China Docetaxel Revenue by Type (2021-2026) & (US$ Million) Table 138. China Docetaxel Revenue by Type (2027-2032) & (US$ Million) Table 139. China Docetaxel Sales by Type (2021-2026) & (K Units) Table 140. China Docetaxel Sales by Type (2027-2032) & (K Units) Table 141. China Docetaxel Sales Price by Type (2021-2026) & (USD/Unit) Table 142. China Docetaxel Sales Price by Type (2027-2032) & (USD/Unit) Table 143. China Docetaxel Revenue by Application (2021-2026) & (US$ Million) Table 144. China Docetaxel Revenue by Application (2027-2032) & (US$ Million) Table 145. China Docetaxel Sales by Application (2021-2026) & (K Units) Table 146. China Docetaxel Sales by Application (2027-2032) & (K Units) Table 147. China Docetaxel Sales Price by Application (2021-2026) & (USD/Unit) Table 148. China Docetaxel Sales Price by Application (2027-2032) & (USD/Unit) Table 149. Asia Docetaxel Revenue by Type (2021-2026) & (US$ Million) Table 150. Asia Docetaxel Revenue by Type (2027-2032) & (US$ Million) Table 151. Asia Docetaxel Sales by Type (2021-2026) & (K Units) Table 152. Asia Docetaxel Sales by Type (2027-2032) & (K Units) Table 153. Asia Docetaxel Sales Price by Type (2021-2026) & (USD/Unit) Table 154. Asia Docetaxel Sales Price by Type (2027-2032) & (USD/Unit) Table 155. Asia Docetaxel Revenue by Application (2021-2026) & (US$ Million) Table 156. Asia Docetaxel Revenue by Application (2027-2032) & (US$ Million) Table 157. Asia Docetaxel Sales by Application (2021-2026) & (K Units) Table 158. Asia Docetaxel Sales by Application (2027-2032) & (K Units) Table 159. Asia Docetaxel Sales Price by Application (2021-2026) & (USD/Unit) Table 160. Asia Docetaxel Sales Price by Application (2027-2032) & (USD/Unit) Table 161. Asia Docetaxel Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. Asia Docetaxel Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 163. Asia Docetaxel Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 164. Asia Docetaxel Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 165. Asia Docetaxel Sales by Country (2021-2026) & (K Units) Table 166. Asia Docetaxel Sales by Country (2027-2032) & (K Units) Table 167. Asia Docetaxel Sales Price by Country (2021-2026) & (USD/Unit) Table 168. Asia Docetaxel Sales Price by Country (2027-2032) & (USD/Unit) Table 169. Japan Docetaxel Revenue (2021-2032) & (US$ Million) Table 170. South Korea Docetaxel Revenue (2021-2032) & (US$ Million) Table 171. India Docetaxel Revenue (2021-2032) & (US$ Million) Table 172. Australia Docetaxel Revenue (2021-2032) & (US$ Million) Table 173. Taiwan Docetaxel Revenue (2021-2032) & (US$ Million) Table 174. Southeast Asia Docetaxel Revenue (2021-2032) & (US$ Million) Table 175. SAMEA Docetaxel Revenue by Type (2021-2026) & (US$ Million) Table 176. SAMEA Docetaxel Revenue by Type (2027-2032) & (US$ Million) Table 177. SAMEA Docetaxel Sales by Type (2021-2026) & (K Units) Table 178. SAMEA Docetaxel Sales by Type (2027-2032) & (K Units) Table 179. SAMEA Docetaxel Sales Price by Type (2021-2026) & (USD/Unit) Table 180. SAMEA Docetaxel Sales Price by Type (2027-2032) & (USD/Unit) Table 181. SAMEA Docetaxel Revenue by Application (2021-2026) & (US$ Million) Table 182. SAMEA Docetaxel Revenue by Application (2027-2032) & (US$ Million) Table 183. SAMEA Docetaxel Sales by Application (2021-2026) & (K Units) Table 184. SAMEA Docetaxel Sales by Application (2027-2032) & (K Units) Table 185. SAMEA Docetaxel Sales Price by Application (2021-2026) & (USD/Unit) Table 186. SAMEA Docetaxel Sales Price by Application (2027-2032) & (USD/Unit) Table 187. SAMEA Docetaxel Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 188. SAMEA Docetaxel Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 189. SAMEA Docetaxel Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 190. SAMEA Docetaxel Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 191. SAMEA Docetaxel Sales by Country (2021-2026) & (K Units) Table 192. SAMEA Docetaxel Sales by Country (2027-2032) & (K Units) Table 193. SAMEA Docetaxel Sales Price by Country (2021-2026) & (USD/Unit) Table 194. SAMEA Docetaxel Sales Price by Country (2027-2032) & (USD/Unit) Table 195. Brazil Docetaxel Revenue (2021-2032) & (US$ Million) Table 196. Argentina Docetaxel Revenue (2021-2032) & (US$ Million) Table 197. Chile Docetaxel Revenue (2021-2032) & (US$ Million) Table 198. Colombia Docetaxel Revenue (2021-2032) & (US$ Million) Table 199. Peru Docetaxel Revenue (2021-2032) & (US$ Million) Table 200. Saudi Arabia Docetaxel Revenue (2021-2032) & (US$ Million) Table 201. Israel Docetaxel Revenue (2021-2032) & (US$ Million) Table 202. UAE Docetaxel Revenue (2021-2032) & (US$ Million) Table 203. Turkey Docetaxel Revenue (2021-2032) & (US$ Million) Table 204. Iran Docetaxel Revenue (2021-2032) & (US$ Million) Table 205. Egypt Docetaxel Revenue (2021-2032) & (US$ Million) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Docetaxel Distributors List Table 209. Docetaxel Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Docetaxel Image Figure 2. Global Docetaxel Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Docetaxel Market Size Share 2021 VS 2025 VS 2032 Figure 4. 20 mg/ml Image Figure 5. 40 mg/ml Image Figure 6. 60 mg/ml Image Figure 7. Global Docetaxel Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Docetaxel Market Size Share 2021 VS 2025 VS 2032 Figure 9. Breast Cancer Image Figure 10. Prostate Cancer Image Figure 11. Non-small Cell Lung Cancer Image Figure 12. Others Image Figure 13. Global Docetaxel Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Docetaxel Revenue (2021-2032) & (US$ Million) Figure 15. Global Docetaxel Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Docetaxel Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Docetaxel Revenue Market Share by Region (2021-2032) Figure 18. Global Docetaxel Sales (2021-2032) & (K Units) Figure 19. Global Docetaxel Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Docetaxel Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Docetaxel Sales YoY (2021-2032) & (K Units) Figure 22. Europe Docetaxel Sales YoY (2021-2032) & (K Units) Figure 23. China Docetaxel Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Docetaxel Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Docetaxel Sales YoY (2021-2032) & (K Units) Figure 26. Global Docetaxel Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Docetaxel Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Docetaxel Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Docetaxel Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Docetaxel Revenue Market Share by Type (2021-2032) Figure 32. Global Docetaxel Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Docetaxel Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Docetaxel Sales Market Share by Type (2021-2032) Figure 35. Global Docetaxel Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Docetaxel Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Docetaxel Revenue Market Share by Application (2021-2032) Figure 38. Global Docetaxel Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Docetaxel Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Docetaxel Sales Market Share by Application (2021-2032) Figure 41. North America Docetaxel Revenue Share by Type (2021-2032) Figure 42. North America Docetaxel Sales Share by Type (2021-2032) Figure 43. North America Docetaxel Revenue Share by Application (2021-2032) Figure 44. North America Docetaxel Sales Share by Application (2021-2032) Figure 45. North America Docetaxel Revenue Share by Country (2021-2032) Figure 46. North America Docetaxel Sales Share by Country (2021-2032) Figure 47. Europe Docetaxel Revenue Share by Type (2021-2032) Figure 48. Europe Docetaxel Sales Share by Type (2021-2032) Figure 49. Europe Docetaxel Revenue Share by Application (2021-2032) Figure 50. Europe Docetaxel Sales Share by Application (2021-2032) Figure 51. Europe Docetaxel Revenue Share by Country (2021-2032) Figure 52. Europe Docetaxel Sales Share by Country (2021-2032) Figure 53. China Docetaxel Revenue Share by Type (2021-2032) Figure 54. China Docetaxel Sales Share by Type (2021-2032) Figure 55. China Docetaxel Revenue Share by Application (2021-2032) Figure 56. China Docetaxel Sales Share by Application (2021-2032) Figure 57. Asia Docetaxel Revenue Share by Type (2021-2032) Figure 58. Asia Docetaxel Sales Share by Type (2021-2032) Figure 59. Asia Docetaxel Revenue Share by Application (2021-2032) Figure 60. Asia Docetaxel Sales Share by Application (2021-2032) Figure 61. Asia Docetaxel Revenue Share by Country (2021-2032) Figure 62. Asia Docetaxel Sales Share by Country (2021-2032) Figure 63. SAMEA Docetaxel Revenue Share by Type (2021-2032) Figure 64. SAMEA Docetaxel Sales Share by Type (2021-2032) Figure 65. SAMEA Docetaxel Revenue Share by Application (2021-2032) Figure 66. SAMEA Docetaxel Sales Share by Application (2021-2032) Figure 67. SAMEA Docetaxel Revenue Share by Country (2021-2032) Figure 68. SAMEA Docetaxel Sales Share by Country (2021-2032) Figure 69. Docetaxel Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Docetaxel Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 20 mg/ml
  • 40 mg/ml
  • 60 mg/ml
Applications
  • Breast Cancer
  • Prostate Cancer
  • Non-small Cell Lung Cancer
  • Others
Companies covered
  • Hengrui Medicine
  • Sanofi
  • Qilu Pharma
  • Shenzhen Main Luck Pharma
  • Jiangsu Aosaikang Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Docetaxel Market by Type
  3. 1.2.1 Global Docetaxel Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 20 mg/ml
  5. 1.2.3 40 mg/ml
  6. 1.2.4 60 mg/ml
  7. 1.3 Docetaxel Market by Application
  8. 1.3.1 Global Docetaxel Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Breast Cancer
  10. 1.3.3 Prostate Cancer
  11. 1.3.4 Non-small Cell Lung Cancer
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Docetaxel Market Dynamics
  1. 2.1 Docetaxel Industry Trends
  2. 2.2 Docetaxel Industry Drivers
  3. 2.3 Docetaxel Industry Opportunities and Challenges
  4. 2.4 Docetaxel Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Docetaxel Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Docetaxel Revenue by Region
  3. 3.2.1 Global Docetaxel Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Docetaxel Revenue by Region (2021-2026)
  5. 3.2.3 Global Docetaxel Revenue by Region (2027-2032)
  6. 3.2.4 Global Docetaxel Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Docetaxel Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Docetaxel Sales by Region
  9. 3.4.1 Global Docetaxel Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Docetaxel Sales by Region (2021-2026)
  11. 3.4.3 Global Docetaxel Sales by Region (2027-2032)
  12. 3.4.4 Global Docetaxel Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Docetaxel Revenue by Manufacturers
  2. 4.1.1 Global Docetaxel Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Docetaxel Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Docetaxel Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Docetaxel Sales by Manufacturers
  6. 4.2.1 Global Docetaxel Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Docetaxel Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Docetaxel Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Docetaxel Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Docetaxel Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Docetaxel Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Docetaxel Manufacturers, Product Type & Application
  13. 4.7 Global Docetaxel Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Docetaxel Market CR5 and HHI
  16. 4.8.2 2025 Docetaxel Tier 1, Tier 2, and Tier 3
5 Docetaxel Market by Type
  1. 5.1 Global Docetaxel Revenue by Type
  2. 5.1.1 Global Docetaxel Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Docetaxel Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Docetaxel Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Docetaxel Sales by Type
  6. 5.2.1 Global Docetaxel Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Docetaxel Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Docetaxel Sales Market Share by Type (2021-2032)
  9. 5.3 Global Docetaxel Price by Type
6 Docetaxel Market by Application
  1. 6.1 Global Docetaxel Revenue by Application
  2. 6.1.1 Global Docetaxel Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Docetaxel Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Docetaxel Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Docetaxel Sales by Application
  6. 6.2.1 Global Docetaxel Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Docetaxel Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Docetaxel Sales Market Share by Application (2021-2032)
  9. 6.3 Global Docetaxel Price by Application
7 Company Profiles
  1. 7.1 Hengrui Medicine
  2. 7.1.1 Hengrui Medicine Company Information
  3. 7.1.2 Hengrui Medicine Business Overview
  4. 7.1.3 Hengrui Medicine Docetaxel Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Hengrui Medicine Docetaxel Product Portfolio
  6. 7.1.5 Hengrui Medicine Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi Docetaxel Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Docetaxel Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
  13. 7.3 Qilu Pharma
  14. 7.3.1 Qilu Pharma Company Information
  15. 7.3.2 Qilu Pharma Business Overview
  16. 7.3.3 Qilu Pharma Docetaxel Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Qilu Pharma Docetaxel Product Portfolio
  18. 7.3.5 Qilu Pharma Recent Developments
  19. 7.4 Shenzhen Main Luck Pharma
  20. 7.4.1 Shenzhen Main Luck Pharma Company Information
  21. 7.4.2 Shenzhen Main Luck Pharma Business Overview
  22. 7.4.3 Shenzhen Main Luck Pharma Docetaxel Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Shenzhen Main Luck Pharma Docetaxel Product Portfolio
  24. 7.4.5 Shenzhen Main Luck Pharma Recent Developments
  25. 7.5 Jiangsu Aosaikang Pharma
  26. 7.5.1 Jiangsu Aosaikang Pharma Company Information
  27. 7.5.2 Jiangsu Aosaikang Pharma Business Overview
  28. 7.5.3 Jiangsu Aosaikang Pharma Docetaxel Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Jiangsu Aosaikang Pharma Docetaxel Product Portfolio
  30. 7.5.5 Jiangsu Aosaikang Pharma Recent Developments
8 North America
  1. 8.1 North America Docetaxel Market Size by Type
  2. 8.1.1 North America Docetaxel Revenue by Type (2021-2032)
  3. 8.1.2 North America Docetaxel Sales by Type (2021-2032)
  4. 8.1.3 North America Docetaxel Price by Type (2021-2032)
  5. 8.2 North America Docetaxel Market Size by Application
  6. 8.2.1 North America Docetaxel Revenue by Application (2021-2032)
  7. 8.2.2 North America Docetaxel Sales by Application (2021-2032)
  8. 8.2.3 North America Docetaxel Price by Application (2021-2032)
  9. 8.3 North America Docetaxel Market Size by Country
  10. 8.3.1 North America Docetaxel Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Docetaxel Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Docetaxel Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Docetaxel Market Size by Type
  2. 9.1.1 Europe Docetaxel Revenue by Type (2021-2032)
  3. 9.1.2 Europe Docetaxel Sales by Type (2021-2032)
  4. 9.1.3 Europe Docetaxel Price by Type (2021-2032)
  5. 9.2 Europe Docetaxel Market Size by Application
  6. 9.2.1 Europe Docetaxel Revenue by Application (2021-2032)
  7. 9.2.2 Europe Docetaxel Sales by Application (2021-2032)
  8. 9.2.3 Europe Docetaxel Price by Application (2021-2032)
  9. 9.3 Europe Docetaxel Market Size by Country
  10. 9.3.1 Europe Docetaxel Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Docetaxel Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Docetaxel Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Docetaxel Market Size by Type
  2. 10.1.1 China Docetaxel Revenue by Type (2021-2032)
  3. 10.1.2 China Docetaxel Sales by Type (2021-2032)
  4. 10.1.3 China Docetaxel Price by Type (2021-2032)
  5. 10.2 China Docetaxel Market Size by Application
  6. 10.2.1 China Docetaxel Revenue by Application (2021-2032)
  7. 10.2.2 China Docetaxel Sales by Application (2021-2032)
  8. 10.2.3 China Docetaxel Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Docetaxel Market Size by Type
  2. 11.1.1 Asia Docetaxel Revenue by Type (2021-2032)
  3. 11.1.2 Asia Docetaxel Sales by Type (2021-2032)
  4. 11.1.3 Asia Docetaxel Price by Type (2021-2032)
  5. 11.2 Asia Docetaxel Market Size by Application
  6. 11.2.1 Asia Docetaxel Revenue by Application (2021-2032)
  7. 11.2.2 Asia Docetaxel Sales by Application (2021-2032)
  8. 11.2.3 Asia Docetaxel Price by Application (2021-2032)
  9. 11.3 Asia Docetaxel Market Size by Country
  10. 11.3.1 Asia Docetaxel Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Docetaxel Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Docetaxel Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Docetaxel Market Size by Type
  2. 12.1.1 SAMEA Docetaxel Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Docetaxel Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Docetaxel Price by Type (2021-2032)
  5. 12.2 SAMEA Docetaxel Market Size by Application
  6. 12.2.1 SAMEA Docetaxel Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Docetaxel Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Docetaxel Price by Application (2021-2032)
  9. 12.3 SAMEA Docetaxel Market Size by Country
  10. 12.3.1 SAMEA Docetaxel Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Docetaxel Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Docetaxel Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Docetaxel Value Chain Analysis
  2. 13.1.1 Docetaxel Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Docetaxel Production Mode & Process
  6. 13.2 Docetaxel Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Docetaxel Distributors
  9. 13.2.3 Docetaxel Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst